Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.35M Buy
248,337
+187,324
+307% +$4.5M ﹤0.01% 2057
2026
Q1
$1.53M Hold
61,013
﹤0.01% 2377
2025
Q4
$1.46M Hold
61,013
﹤0.01% 2426
2025
Q3
$1.43M Hold
61,013
﹤0.01% 2449
2025
Q2
$1.35M Hold
61,013
﹤0.01% 2469
2025
Q1
$1.4M Sell
61,013
-10,448
-15% -$246K ﹤0.01% 2485
2024
Q4
$1.66M Sell
71,461
-547
-0.8% -$15.7K ﹤0.01% 2460
2024
Q3
$2.51M Hold
72,008
﹤0.01% 2306
2024
Q2
$2.34M Sell
72,008
-1,261
-2% -$42K ﹤0.01% 2306
2024
Q1
$2.5M Buy
73,269
+14,602
+25% +$556K ﹤0.01% 2295
2023
Q4
$2.33M Buy
+58,667
New +$2.27M ﹤0.01% 2344

Other funds holding BCE

Nuveen's BCE Position: Q2 2026 in Review

Nuveen increased its BCE (BCE) stake by 307% in Q2 2026, buying an estimated $4.5M and bringing the position to 248,337 shares worth $5.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Nuveen first reported a position in BCE in Q4 2023 and has held it in 11 quarters since. 392 funds tracked by Wall St. Rank hold BCE as of Q2 2026.

  • Nuveen held 248,337 shares of BCE worth $5.35M as of Q2 2026.
  • Nuveen bought 187,324 BCE shares in Q2 2026, an estimated $4.5M.
  • BCE made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2057 holding.
  • Nuveen first reported a position in BCE in Q4 2023 and has held it in 11 quarters since.
  • 392 funds tracked by Wall St. Rank held BCE as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.